QUAY PHARMACEUTICALS

Our commitment to this field is ongoing as we complete new GMP suites dedicated to taking microbiome therapeutic products into larger-scale Phase II and III trials and delivering new groundbreaking microbiome-based medicines to our customers... We are known for our scientific creativity and innovation in development, as well as our flexibility and pragmatism for managing projects towards clinical trials, helping our customers overcome many scientific and technical challenges along the way... We create robust formulation development strategies tailored to the characteristics of each individual API with a proven track record of developing formulations containing anaerobes, bacteriophages, GMO strains, and human-derived consortia into safe, effective dosage forms.

Also known as: Quay Pharmaceuticals LLC

Primary location: Hudson United States